BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25413689)

  • 41. Fetomaternal AB0 incompatibility and erythroblastosis fetalis.
    Bowman JM
    Vox Sang; 1986; 50(2):104-6. PubMed ID: 3083588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of immunoprophylaxis with anti-D immunoglobin.
    Engelfriet CP; Reesink HW; Judd WJ; Ulander VM; Kuosmanen M; Koskinen S; Rouger P; Morelati F; Tantalo V; Fujii T; de Haas M; van der Schoot CE; Overbeeke M; Koelewijn J; Bonsel G; Vrijkotte T; Zupańska B; Martin-Vega C; Parra Lopez R; de Silva M; Contreras M; Panzer S; Ulm B; Mayr WR
    Vox Sang; 2003 Nov; 85(4):328-37. PubMed ID: 14633261
    [No Abstract]   [Full Text] [Related]  

  • 43. [Fetal plasma erythropoietin concentration during intrauterine transfusion therapy in isoimmunohemolytic anemia due to rhesus incompatibility].
    Hebgen A; Schiffer-N'Gampolo D; Bald R; Hansmann M; Bode U
    Ultraschall Med; 1997 Aug; 18(4):162-4. PubMed ID: 9381123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrops fetalis associated with immunologic and nonimmunologic factors.
    Vintzileos AM; Campbell WA; Deaton JL; Nochimson DJ; Weinbaum PJ
    Am J Perinatol; 1987 Apr; 4(2):115-20. PubMed ID: 3105548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 46. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunologic aspects of plasmapheresis in series of Rh negative pregnant women].
    Correa N; Goméz G; Rubinstein P
    Rev Chil Obstet Ginecol; 1976; 41(7):257-8. PubMed ID: 829286
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune cytopenias in newborns].
    Brossard Y
    Rev Prat; 2001 Sep; 51(14):1571-6. PubMed ID: 11757274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy--effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja)?].
    Heim MU; Weidemann R; Brehm G; Versmold H; Mempel W
    Beitr Infusionsther; 1990; 26():302-6. PubMed ID: 1703859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound-guided fetal intravascular transfusion in a case of severe rhesus isoimmunization.
    Piiroinen O; Erkkola R; Grönroos M
    Ann Chir Gynaecol Suppl; 1987; 202():5-7. PubMed ID: 2444147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of fetal hemolytic disease using plasmapheresis].
    Schwarzlos G; During R; Müller S; Stark KH; Plesse R
    Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.